GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 23.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,159 shares of the company's stock after selling 4,231 shares during the period. Edmond DE Rothschild Holding S.A.'s holdings in GE HealthCare Technologies were worth $1,107,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. FMR LLC boosted its position in shares of GE HealthCare Technologies by 4.1% in the 3rd quarter. FMR LLC now owns 2,165,826 shares of the company's stock valued at $203,263,000 after purchasing an additional 84,411 shares during the period. Townsquare Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 21.5% in the third quarter. Townsquare Capital LLC now owns 7,722 shares of the company's stock valued at $725,000 after acquiring an additional 1,366 shares during the period. CreativeOne Wealth LLC purchased a new position in shares of GE HealthCare Technologies during the third quarter worth approximately $259,000. Captrust Financial Advisors increased its holdings in shares of GE HealthCare Technologies by 1.6% in the 3rd quarter. Captrust Financial Advisors now owns 33,353 shares of the company's stock valued at $3,130,000 after acquiring an additional 534 shares during the period. Finally, Verition Fund Management LLC raised its position in GE HealthCare Technologies by 15.4% in the 3rd quarter. Verition Fund Management LLC now owns 15,798 shares of the company's stock valued at $1,483,000 after purchasing an additional 2,113 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on GEHC. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $97.73.

GE HealthCare Technologies Price Performance

GEHC traded down $11.49 on Friday, hitting $60.51. 16,885,304 shares of the company were exchanged, compared to its average volume of 3,023,599. The business's fifty day moving average is $85.41 and its 200 day moving average is $85.43. GE HealthCare Technologies Inc. has a fifty-two week low of $58.04 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market capitalization of $27.67 billion, a P/E ratio of 13.97, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.23%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.